U.S., Sept. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07813364) titled 'Facing Fears From Home: Development, Feasibility and Maximization of FobiApp' on July 23.
Brief Summary: The aim of this study is to evaluate the feasibility (including usability, acceptance and satisfaction) and preliminary effectiveness of a smartphone App for self-administered exposure therapy using Augmented reality for cockroach phobia (FobiApp), compared to the same self-administered exposure therapy combined with training in attentional bias modification (ABM).
Study Start Date: Oct., 2026
Study Type: INTERVENTIONAL
Condition:
Specific Phobia
Intervention:
BEHAVIORAL: FobiApp AR Exposure therapy, Self-administered augm...